MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Cognitive dysfunction"

  • MDS Virtual Congress 2020

    Donepezil for mild cognitive impairment in Parkinson’s disease: A 48-week follow-up study

    K. Baik, S. Kim, S. Kang, Y. Sohn, P. Lee, S. Kang (Seoul, Republic of Korea)

    Objective: To investigate the efficacy of donepezil for mild cognitive impairment (MCI) in Parkinson’s disease (PD). Background: MCI is common in PD. The mechanism of…
  • MDS Virtual Congress 2020

    APOE, TREM2 and LINGO1 genes: A possible implication in cognition in essential tremor in a Tunisian population

    G. Ali Barreh, A. Nasri, S. Zidi, A. Rekik, S. Mrabet, I. Kacem, M. Ben Djebara, R. Gouider (La Manouba, Tunisia)

    Objective: To investigate the effect of polymorphisms in APOE, TREM2 and LINGO1 genes on the cognitive profile of essential tremor(ET) in Tunisian population. Background: ET…
  • MDS Virtual Congress 2020

    Quantitative method for designing appropriate longitudinal follow-up frequency with application to Parkinson’s disease cognition research

    L. Suttner, S. Xie (Philadelphia, PA, USA)

    Objective: To develop a quantitative method for designing appropriate longitudinal follow-up frequency. We demonstrate how to use this new method using a progression study of…
  • MDS Virtual Congress 2020

    Serum Neurofilament light chain levels and disability milestones in Lewy body diseases

    A. Pilotto, A. Imarisio, F. Conforti, A. Lupini, G. Giannì, S. Gipponi, E. Cottini, A. Scalvini, S. Masciocchi, S. Nocivelli, R. Grasso, R. Turrone, B. Borroni, M. Rizzetti, L. Bonanni, M. Pizzi, A. Bellucci, E. Garraffa, H. Zetterberg, N. Ashton, A. Hye, A. Padovani (Brescia, Italy)

    Objective: To evaluate the relationship between motor, cognitive and autonomic symptoms and serum Neurofilament light chain levels in Lewy bodies disorders, namely Parkinson' s disease…
  • MDS Virtual Congress 2020

    The interplay between asymmetric dopaminergic degeneration, brain structural changes and cognition in de-novo PD: The PPMI dataset

    E. Fiorenzato, A. Antonini, W. Weis, P. Bisiacchi, C. Semenza, A. Vallesi, R. Biundo (Venice, Italy)

    Objective: To characterize the impact of asymmetric dopaminergic degeneration, measured with I123-ioflupane SPECT (DATSCAN), on cortical integrity and cognitive deficits, in de-novo right-handed PD patients.…
  • MDS Virtual Congress 2020

    Clinician Ratings of Cognition Predict Trajectory of Cognitive Decline in Newly Diagnosed Individuals with Parkinson’s disease

    F. Lopez, E. Trifilio, A. Ratajska, L. Kenney, D. Bowers (Gainesville, FL, USA)

    Objective: The overall goal of this study was to learn whether clinician ratings of cognition would predict trajectory of changes in memory performance over a…
  • MDS Virtual Congress 2020

    Cognitive impairment related networks of functional MRI in Parkinson’s disease

    W. Sako, T. Abe, Y. Matsumoto, S. Haji, Y. Osaki, M. Harada, Y. Izumi (Tokushima, Japan)

    Objective: This study attempts to identify cognitive impairment related networks in the subjects with Parkinson’s disease using functional magnetic resonance imaging (MRI). Background: Voxelwise analysis…
  • MDS Virtual Congress 2020

    Cognitive profiling of patients with neurodegenerative disorders

    I. Zhukova, E. Kolupaeva, N. Zhukova, O. Izhboldina, M. Nikitina, A. Latipova, S. Shtaymets, I. Mironova, Z.h Kislukhina, L. Tkachenko, A. Agasheva, D. Novotnyy (Tomsk, Russian Federation)

    Objective: To characterise the cognitive decline of patients with neurodegenerative disorders: Parkinson’s disease (PD), Alzheimer's disease (AD) and essential tremor (ET) and to compare their neuropsychological…
  • MDS Virtual Congress 2020

    Altered metabolic and functional resting state activity in cognitively unimpaired and impaired Parkinson’s disease patients

    M. Ruppert, A. Greuel, M. Tahmasian, K. Steidel, F. Maier, J. Hammes, T. van Eimeren, L. Timmermann, M. Tittgemeyer, A. Drzezga, C. Eggers (Marburg, Germany)

    Objective: To assess the correspondence between functional connectivity and metabolic covariance in healthy controls and Parkinson’s disease patients (PD) with and without cognitive impairment. Background:…
  • MDS Virtual Congress 2020

    Blood-Brain Barrier Opening with Focused Ultrasound in Parkinson´s Disease with Cognitive Impairment: A Safety and Feasibility Study

    C. Gasca-Salas, J. Pineda-Pardo, B. Fernández-Rodríguez, R. Rodríguez-Rojas, F. Hernández, I. Obeso, M. del Álamo, P. Guida, D. Mata-Marin, R. Martínez-Fernández, C. Ordás-Bandera, G. Foffani, I. Rachmilevitch, J. Obeso (Móstoles, Spain)

    Objective: To evaluate the safety and feasibility of MR guided focused ultrasound (MRgFUS) blood-brain barrier (BBB) opening in the cortex or the striatum in Parkinson´s…
  • « Previous Page
  • 1
  • …
  • 52
  • 53
  • 54
  • 55
  • 56
  • …
  • 117
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Patients with Essential Tremor Live Longer than their Relatives
  • #23624 (not found)
  • The hardest symptoms that bother patients with Parkinson's disease
  • Three cases of early tremor in the course of Guillain-Barré Syndrome
  • The impact of gastric acid suppressants and antacids on levodopa plasma concentration in patients with Parkinson’s disease
  • To be or not to bupropion: a drug-induced parkinsonism?
  • The Role of MRI and DaTscan in Vascular Parkinsonism: A Case Report
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley